eujobs.coEU jobs in brussels
Post a JobHeadhunter

Aspen Pharmacare

Acronym: ASP

General Information

Identification Code: 204680631588-97
Website: [object Object]
Entity Form: Holdings Limited
Registration Category: Companies & groups
Registration Date: 5/22/2018
Last Update: 9/12/2023
EP Accredited Number: 0

Mission & Interests

Goals: Aspen Pharmacare is a South-African pharmaceutical company. Aspen operates with an established business presence in approximately 50 countries and supply products in more than 150 countries. We have a proud heritage dating back more than 160 years and are committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products. We are a leading global player in specialty and branded pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to benefit the lives of patients using our products in more than 150 countries. Aspen has identified Anaesthetics, High Potency & Cytotoxics, Antthrombotics and Nutritionals as our focused therapeutic categories that will receive our highest focus based on materiality and future potential. We operate 25 manufacturing facilities across 17 sites.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Business and industry
  • Environment
  • External relations
  • Humanitarian aid and civil protection
  • Institutional affairs
  • International co-operation and development
  • Public health
  • Trade
Levels of Interest:
  • global
  • european

Activities

Main EU Legislative Proposals: Aspen currently follows European policies, legislative files related to our Pharmaceuticals and any EU project(mainly in Anesthetesia and Oncology). We are particularly interested in European initiatives to support medicine affordability to patients and any initiatives to support production investment in the European countries. Our domains of interest includes also Data Protection Regulation, Brexit consequences, Pharmaceutical Industry strategy, and EU pricing & trade Policy.
Communication Activities: Application of King IV and compliance with the Companies Act The Group continuously strives to enhance its application of King IV and to ensure its ongoing compliance with the South African Companies Act, 2008 (“Companies Act”). The application of the King IV principles and adoption of the various recommendations are published online. https://www.aspenpharma.com/corporate-governance/
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Aspen Place9 Rydall Vale Park
Post Code: Gateway, 4321
City: Durban
Country: SOUTH AFRICA
Phone: [object Object]

EU Office

Address: Montgelasstrasse 14
Post Code: 81679
City: München
Country: GERMANY
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]

Membership Information

Members10 Percent: 1
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.10000000149011612
Info Members: Current Position: Market Access & Tender Management Lead; overviewing EU Pharma Activities like Revision of EU general pharmaceutical legislation; EU Proposed directive on corporate sustainability due diligence, Relevance of the Green Deal,

Structure

Structure Type: Structure
Is Member Of: https://www.aspenpharma.com/board-of-directors/
Organisation Members: https://www.aspenpharma.com/we-care/